Matthew Gline Roivant Sciences Ltd. (ROIV) insider trading activity
Matthew Gline is CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 17.3 Million shares of ROIV, which is worth approximately $194 Million. The most recent transaction as insider was on Jul 25, 2022, when has been sold 20,455 shares (Common Shares) at a price of $4.33 per share, resulting in proceeds of $88,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
17.3M
0.13%
3M change
1427.08%
12M change
Total Value Held
$194 Million
Matthew Gline Transaction History
MG
Matthew Gline
CEO
London, X0